TNF and rheumatoid arthritis: A similar trend in increase of anti-TNF therapy-related costs has been found in rheumatoid arthritis.[14;15] In two national registry cost-of-illness studies covering 20-years of follow-up, a downward trend for all costs, apart from the costs for anti-TNF, therapy has been reported.